The European Society for Human Genetics (ESHG) has made a strong statement against the use of polygenic risk scores (PRS) for pre-implantation genetic testing of embryos .

Some private fertility clinics have begun to sell polygenic risk scores (PRSs) analyses on embryos to prospective parents. This practice raises many concerns, representatives from the European Society of Human Genetics told a media briefing in London (Tuesday 25 January). In a paper published in the European Journal of Human Genetics, they say that there is no evidence that PRSs can predict the likelihood of as-yet unborn children being liable to a specific disease in the future. Read the full article here